{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:41:56Z","timestamp":1792788116106,"version":"4.5.0"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T00:00:00Z","timestamp":1765411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Sun Yat-Sen University Clinical Research 5010 Program","award":["2023010"],"award-info":[{"award-number":["2023010"]}]},{"name":"1010 Project of the Sixth Affiliated Hospital of Sun Yat-sen University","award":["1010CG (2022)-06"],"award-info":[{"award-number":["1010CG (2022)-06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"DOI":"10.1186\/s12943-025-02478-5","type":"journal-article","created":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T06:00:21Z","timestamp":1765432821000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["CircZFAND6 suppresses gastric cancer metastasis and reduces resistance to TKI therapy"],"prefix":"10.1186","volume":"24","author":[{"given":"Zi-Jian","family":"Deng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ying","family":"OuYang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Ping","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huan-Ting","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shu-Li","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong-Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian-Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Sheng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,11]]},"reference":[{"issue":"3","key":"2478_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10294","key":"2478_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S0140-6736(21)00797-2","volume":"398","author":"YY Janjigian","year":"2021","unstructured":"Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398(10294):27\u201340.","journal-title":"Lancet"},{"issue":"2","key":"2478_CR3","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1016\/S1470-2045(21)00692-6","volume":"23","author":"YK Kang","year":"2022","unstructured":"Kang YK, Chen LT, Ryu MH, Oh DY, Oh SC, Chung HC, et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2022;23(2):234\u201347.","journal-title":"Lancet Oncol"},{"issue":"7903","key":"2478_CR4","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41586-022-04508-4","volume":"603","author":"K Shitara","year":"2022","unstructured":"Shitara K, Ajani JA, Moehler M, Garrido M, Gallardo C, Shen L, et al. Nivolumab plus chemotherapy or ipilimumab in gastro-oesophageal cancer. Nature. 2022;603(7903):942\u20138.","journal-title":"Nature"},{"issue":"7441","key":"2478_CR5","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495(7441):384\u20138.","journal-title":"Nature"},{"issue":"1","key":"2478_CR6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","volume":"66","author":"I Legnini","year":"2017","unstructured":"Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66(1):22\u2013e379.","journal-title":"Mol Cell"},{"issue":"6","key":"2478_CR7","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.cell.2015.02.014","volume":"160","author":"SJ Conn","year":"2015","unstructured":"Conn SJ, Pillman KA, Toubia J, Conn VM, Salmanidis M, Phillips CA, et al. The RNA binding protein quaking regulates formation of circrnas. Cell. 2015;160(6):1125\u201334.","journal-title":"Cell"},{"issue":"3","key":"2478_CR8","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22(3):256\u201364.","journal-title":"Nat Struct Mol Biol"},{"issue":"4","key":"2478_CR9","doi-asserted-by":"publisher","first-page":"372","DOI":"10.2478\/jtim-2023-0122","volume":"11","author":"J Xie","year":"2023","unstructured":"Xie J, Ye F, Deng X, Tang Y, Liang JY, Huang X, et al. Circular RNA: a promising new star of vaccine. J Transl Intern Med. 2023;11(4):372\u201381.","journal-title":"J Transl Intern Med"},{"key":"2478_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.drup.2024.101126","volume":"77","author":"Y Zou","year":"2024","unstructured":"Zou Y, Yang A, Chen B, Deng X, Xie J, Dai D, et al. crVDAC3 alleviates ferroptosis by impeding HSPB1 ubiquitination and confers trastuzumab Deruxtecan resistance in HER2-low breast cancer. Drug Resist Updat. 2024;77:101126.","journal-title":"Drug Resist Updat"},{"key":"2478_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2024.216907","volume":"592","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Tan Y, Yuan J, Tang H, Zhang H, Tang Y, et al. CircLIFR-007 reduces liver metastasis via promoting hnRNPA1 nuclear export and YAP phosphorylation in breast cancer. Cancer Lett. 2024;592:216907.","journal-title":"Cancer Lett"},{"issue":"13","key":"2478_CR12","doi-asserted-by":"publisher","first-page":"2574","DOI":"10.7150\/jca.86940","volume":"14","author":"Z Zhou","year":"2023","unstructured":"Zhou Z, Qin J, Song C, Wu T, Quan Q, Zhang Y, et al. CircROBO1 promotes prostate cancer growth and enzalutamide resistance via accelerating glycolysis. J Cancer. 2023;14(13):2574\u201384.","journal-title":"J Cancer"},{"issue":"1","key":"2478_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/s12943-021-01475-8","volume":"20","author":"DL Chen","year":"2021","unstructured":"Chen DL, Sheng H, Zhang DS, Jin Y, Zhao BT, Chen N, et al. The circular RNA circDLG1 promotes gastric cancer progression and anti-PD-1 resistance through the regulation of CXCL12 by sponging miR-141-3p. Mol Cancer. 2021;20(1):166.","journal-title":"Mol Cancer"},{"issue":"6","key":"2478_CR14","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1016\/j.ymthe.2023.04.013","volume":"31","author":"H Liu","year":"2023","unstructured":"Liu H, Fang D, Zhang C, Zhao Z, Liu Y, Zhao S, et al. Circular MTHFD2L RNA-encoded CM-248aa inhibits gastric cancer progression by targeting the SET-PP2A interaction. Mol Ther. 2023;31(6):1739\u201355.","journal-title":"Mol Ther"},{"key":"2478_CR15","doi-asserted-by":"publisher","DOI":"10.1093\/gastro\/goae008","volume":"12","author":"W Zhang","year":"2024","unstructured":"Zhang W, Yang Q, Qian D, Zhao K, Tang C, Ju S. Deregulation of circRNA hsa_circ_0009109 promotes tumor growth and initiates autophagy by sponging miR-544a-3p in gastric cancer. Gastroenterol Rep. 2024;12:goae008.","journal-title":"Gastroenterol Rep"},{"key":"2478_CR16","doi-asserted-by":"crossref","unstructured":"Agarwal V, Bell GW, Nam JW, Bartel DP. Predicting effective MicroRNA target sites in mammalian mRNAs. eLife. 2015;4:e05005.","DOI":"10.7554\/eLife.05005"},{"issue":"7","key":"2478_CR17","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1080\/15476286.2019.1600395","volume":"16","author":"M Liu","year":"2019","unstructured":"Liu M, Wang Q, Shen J, Yang BB, Ding X. Circbank: a comprehensive database for circrna with standard nomenclature. RNA Biol. 2019;16(7):899\u2013905.","journal-title":"RNA Biol"},{"issue":"10","key":"2478_CR18","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1261\/rna.5248604","volume":"10","author":"M Rehmsmeier","year":"2004","unstructured":"Rehmsmeier M, Steffen P, Hochsmann M, Giegerich R. Fast and effective prediction of microrna\/target duplexes. RNA. 2004;10(10):1507\u201317.","journal-title":"RNA"},{"key":"2478_CR19","volume-title":"The biochemical basis of MicroRNA targeting efficacy","author":"SE McGeary","year":"2019","unstructured":"McGeary SE, Lin KS, Shi CY, Pham TM, Bisaria N, Kelley GM, et al. The biochemical basis of MicroRNA targeting efficacy. Volume 366. New York, NY: Science; 2019. 6472."},{"issue":"Database issue","key":"2478_CR20","doi-asserted-by":"publisher","first-page":"D92","DOI":"10.1093\/nar\/gkt1248","volume":"42","author":"JH Li","year":"2014","unstructured":"Li JH, Liu S, Zhou H, Qu LH, Yang JH. StarBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data. Nucleic Acids Res. 2014;42(Database issue):D92-7.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"2478_CR21","doi-asserted-by":"publisher","first-page":"D127","DOI":"10.1093\/nar\/gkz757","volume":"48","author":"Y Chen","year":"2020","unstructured":"Chen Y, Wang X. MiRDB: an online database for prediction of functional microrna targets. Nucleic Acids Res. 2020;48(D1):D127-31.","journal-title":"Nucleic Acids Res"},{"issue":"10","key":"2478_CR22","doi-asserted-by":"publisher","first-page":"e0206239","DOI":"10.1371\/journal.pone.0206239","volume":"13","author":"C Sticht","year":"2018","unstructured":"Sticht C, De La Torre C, Parveen A, Gretz N. MiRWalk: an online resource for prediction of MicroRNA binding sites. PLoS ONE. 2018;13(10):e0206239.","journal-title":"PLoS ONE"},{"issue":"8","key":"2478_CR23","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/cts.13563","volume":"16","author":"M Posta","year":"2023","unstructured":"Posta M, Gyorffy B. Analysis of a large cohort of pancreatic cancer transcriptomic profiles to reveal the strongest prognostic factors. Clin Transl Sci. 2023;16(8):1479\u201391.","journal-title":"Clin Transl Sci"},{"issue":"6","key":"2478_CR24","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","volume":"149","author":"H Clevers","year":"2012","unstructured":"Clevers H, Nusse R. Wnt\/beta-catenin signaling and disease. Cell. 2012;149(6):1192\u2013205.","journal-title":"Cell"},{"issue":"1","key":"2478_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ccr.2008.06.010","volume":"14","author":"DG DeNardo","year":"2008","unstructured":"DeNardo DG, Johansson M, Coussens LM. Inflaming gastrointestinal oncogenic programming. Cancer Cell. 2008;14(1):7\u20139.","journal-title":"Cancer Cell"},{"issue":"4","key":"2478_CR26","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1007\/s10637-011-9736-z","volume":"30","author":"DJ Adelstein","year":"2012","unstructured":"Adelstein DJ, Rodriguez CP, Rybicki LA, Ives DI, Rice TW. A phase II trial of gefitinib for recurrent or metastatic cancer of the esophagus or gastroesophageal junction. Invest New Drugs. 2012;30(4):1684\u20139.","journal-title":"Invest New Drugs"},{"issue":"26","key":"2478_CR27","doi-asserted-by":"publisher","first-page":"4309","DOI":"10.1200\/JCO.2005.04.2424","volume":"24","author":"F Rojo","year":"2006","unstructured":"Rojo F, Tabernero J, Albanell J, Van Cutsem E, Ohtsu A, Doi T, et al. Pharmacodynamic studies of gefitinib in tumor biopsy specimens from patients with advanced gastric carcinoma. J Clin Oncol. 2006;24(26):4309\u201316.","journal-title":"J Clin Oncol"},{"issue":"1","key":"2478_CR28","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-020-1147-3","volume":"19","author":"P Wu","year":"2020","unstructured":"Wu P, Mo Y, Peng M, Tang T, Zhong Y, Deng X, et al. Emerging role of tumor-related functional peptides encoded by LncRNA and circRNA. Mol Cancer. 2020;19(1):22.","journal-title":"Mol Cancer"},{"issue":"16","key":"2478_CR29","doi-asserted-by":"publisher","first-page":"4536","DOI":"10.3748\/wjg.v20.i16.4536","volume":"20","author":"A Morishita","year":"2014","unstructured":"Morishita A, Gong J, Masaki T. Targeting receptor tyrosine kinases in gastric cancer. World J Gastroenterol. 2014;20(16):4536\u201345.","journal-title":"World J Gastroenterol"},{"issue":"1","key":"2478_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-021-00828-5","volume":"6","author":"Y He","year":"2021","unstructured":"He Y, Sun MM, Zhang GG, Yang J, Chen KS, Xu WW, et al. Targeting PI3K\/Akt signal transduction for cancer therapy. Signal Transduct Target Ther. 2021;6(1):425.","journal-title":"Signal Transduct Target Ther"},{"key":"2478_CR31","doi-asserted-by":"publisher","DOI":"10.34133\/research.0747","volume":"8","author":"S Baldi","year":"2025","unstructured":"Baldi S, Long N, Ma S, Liu L, Al-Danakh A, Yang Q, et al. Advancements in protein kinase inhibitors: from discovery to clinical applications. Research. 2025;8:0747.","journal-title":"Research"},{"issue":"1","key":"2478_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.gene.2005.10.018","volume":"366","author":"N Normanno","year":"2006","unstructured":"Normanno N, De Luca A, Bianco C, Strizzi L, Mancino M, Maiello MR, et al. Epidermal growth factor receptor (EGFR) signaling in cancer. Gene. 2006;366(1):2\u201316.","journal-title":"Gene"},{"issue":"12","key":"2478_CR33","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1002\/j.1460-2075.1994.tb06577.x","volume":"13","author":"SA Prigent","year":"1994","unstructured":"Prigent SA, Gullick WJ. Identification of c-erbB-3 binding sites for phosphatidylinositol 3\u2019-kinase and SHC using an EGF receptor\/c-erbB-3 chimera. EMBO J. 1994;13(12):2831\u201341.","journal-title":"EMBO J"},{"issue":"5","key":"2478_CR34","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1053\/j.gastro.2011.06.070","volume":"141","author":"S Zhu","year":"2011","unstructured":"Zhu S, Belkhiri A, El-Rifai W. DARPP-32 increases interactions between epidermal growth factor receptor and ERBB3 to promote tumor resistance to gefitinib. Gastroenterology. 2011;141(5):1738-e481.","journal-title":"Gastroenterology"},{"issue":"1","key":"2478_CR35","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-024-03132-6","volume":"43","author":"R Xu","year":"2024","unstructured":"Xu R, Du A, Deng X, Du W, Zhang K, Li J, et al. tsRNA-GlyGCC promotes colorectal cancer progression and 5-FU resistance by regulating SPIB. J Exp Clin Cancer Res. 2024;43(1):230.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"2478_CR36","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1007\/s11427-023-2491-7","volume":"67","author":"X Deng","year":"2024","unstructured":"Deng X, Liao T, Xie J, Kang D, He Y, Sun Y, et al. The burgeoning importance of PIWI-interacting RNAs in cancer progression. Sci China Life Sci. 2024;67(4):653\u201362.","journal-title":"Sci China Life Sci"},{"key":"2478_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2023.1297093","volume":"14","author":"A Ghasemian","year":"2023","unstructured":"Ghasemian A, Omear HA, Mansoori Y, Mansouri P, Deng X, Darbeheshti F, et al. Long non-coding RNAs and JAK\/STAT signaling pathway regulation in colorectal cancer development. Front Genet. 2023;14:1297093.","journal-title":"Front Genet"},{"issue":"2","key":"2478_CR38","doi-asserted-by":"publisher","first-page":"145","DOI":"10.2478\/jtim-2023-0089","volume":"11","author":"Y Liu","year":"2023","unstructured":"Liu Y, Liu Y, Ye S, Feng H, Ma L. A new ferroptosis-related signature model including messenger RNAs and long non-coding RNAs predicts the prognosis of gastric cancer patients. J Transl Intern Med. 2023;11(2):145\u201355.","journal-title":"J Transl Intern Med"},{"issue":"1","key":"2478_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01498-9","volume":"21","author":"Z Wang","year":"2022","unstructured":"Wang Z, Yang L, Wu P, Li X, Tang Y, Ou X, et al. The circROBO1\/KLF5\/FUS feedback loop regulates the liver metastasis of breast cancer by inhibiting the selective autophagy of Afadin. Mol Cancer. 2022;21(1):29.","journal-title":"Mol Cancer"},{"key":"2478_CR40","doi-asserted-by":"publisher","first-page":"8035083","DOI":"10.1155\/2022\/8035083","volume":"2022","author":"J Huang","year":"2022","unstructured":"Huang J, Deng X, Chen X, Chang Z, Lu Q, Tang A, et al. Circular RNA KIF4A promotes liver metastasis of breast cancer by reprogramming glucose metabolism. J Oncol. 2022;2022:8035083.","journal-title":"J Oncol"},{"issue":"4","key":"2478_CR41","doi-asserted-by":"publisher","DOI":"10.1111\/cns.14735","volume":"30","author":"M Kohansal","year":"2024","unstructured":"Kohansal M, Alghanimi YK, Banoon SR, Ghasemian A, Afkhami H, Daraei A, et al. Circrna-associated cerna regulatory networks as emerging mechanisms governing the development and biophysiopathology of epilepsy. CNS Neurosci Ther. 2024;30(4):e14735.","journal-title":"CNS Neurosci Ther"},{"key":"2478_CR42","doi-asserted-by":"crossref","unstructured":"Liu A, Jiang B, Song C, Zhong Q, Mo Y, Yang R, et al. Isoliquiritigenin inhibits circ0030018 to suppress glioma tumorigenesis via the miR-1236\/HER2 signaling pathway. MedComm (2020). 2023;4(3):e282.","DOI":"10.1002\/mco2.282"},{"issue":"9","key":"2478_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-022-05261-2","volume":"13","author":"X Tan","year":"2022","unstructured":"Tan X, Liu Z, Wang Y, Wu Z, Zou Y, Luo S, et al. MiR-138-5p-mediated HOXD11 promotes cell invasion and metastasis by activating the FN1\/MMP2\/MMP9 pathway and predicts poor prognosis in penile squamous cell carcinoma. Cell Death Dis. 2022;13(9):816.","journal-title":"Cell Death Dis"},{"issue":"10","key":"2478_CR44","doi-asserted-by":"publisher","DOI":"10.15252\/embj.2022112408","volume":"42","author":"J Yi","year":"2023","unstructured":"Yi J, Wang L, Hu GS, Zhang YY, Du J, Ding JC, et al. CircPVT1 promotes ER-positive breast tumorigenesis and drug resistance by targeting ESR1 and MAVS. EMBO J. 2023;42(10):e112408.","journal-title":"EMBO J"},{"key":"2478_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2022.215778","volume":"543","author":"R Peng","year":"2022","unstructured":"Peng R, Cao J, Su BB, Bai XS, Jin X, Wang AQ, et al. Down-regulation of circPTTG1IP induces hepatocellular carcinoma development via miR-16-5p\/RNF125\/JAK1 axis. Cancer Lett. 2022;543:215778.","journal-title":"Cancer Lett"},{"issue":"1","key":"2478_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-022-01598-6","volume":"21","author":"B Yao","year":"2022","unstructured":"Yao B, Zhu S, Wei X, Chen MK, Feng Y, Li Z, et al. The circSPON2\/miR-331-3p axis regulates PRMT5, an epigenetic regulator of CAMK2N1 transcription and prostate cancer progression. Mol Cancer. 2022;21(1):119.","journal-title":"Mol Cancer"},{"issue":"2","key":"2478_CR47","doi-asserted-by":"publisher","first-page":"170","DOI":"10.2478\/jtim-2022-0055","volume":"12","author":"J Shi","year":"2024","unstructured":"Shi J, Zhou S, Zhao J, Xu D, Huang H, Li M, et al. Microarray analysis of microrna expression in peripheral blood mononuclear cells of patients with polymyositis and dermatomyositis. J Transl Intern Med. 2024;12(2):170\u20136.","journal-title":"J Transl Intern Med"},{"issue":"4","key":"2478_CR48","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1002\/med.21948","volume":"43","author":"HL Ang","year":"2023","unstructured":"Ang HL, Mohan CD, Shanmugam MK, Leong HC, Makvandi P, Rangappa KS, et al. Mechanism of epithelial-mesenchymal transition in cancer and its regulation by natural compounds. Med Res Rev. 2023;43(4):1141\u2013200.","journal-title":"Med Res Rev"},{"key":"2478_CR49","doi-asserted-by":"crossref","unstructured":"Tang Y, Tian W, Zheng S, Zou Y, Xie J, Zhang J, et al. Dissection of FOXO1-Induced LYPLAL1-DT impeding triple-negative breast cancer progression via mediating hnRNPK\/beta-Catenin complex. Research (Wash D C). 2023;6:0289.","DOI":"10.34133\/research.0289"},{"issue":"3","key":"2478_CR50","doi-asserted-by":"publisher","first-page":"848","DOI":"10.7150\/ijbs.91154","volume":"20","author":"R Shao","year":"2024","unstructured":"Shao R, Liu C, Xue R, Deng X, Liu L, Song C, et al. Tumor-derived exosomal ENO2 modulates polarization of tumor-associated macrophages through reprogramming glycolysis to promote progression of diffuse large B-cell lymphoma. Int J Biol Sci. 2024;20(3):848\u201363.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2478_CR51","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-023-01811-0","volume":"22","author":"K Li","year":"2023","unstructured":"Li K, Peng ZY, Wang R, Li X, Du N, Liu DP, et al. Enhancement of TKI sensitivity in lung adenocarcinoma through m6A-dependent translational repression of Wnt signaling by circ-FBXW7. Mol Cancer. 2023;22(1):103.","journal-title":"Mol Cancer"},{"issue":"1","key":"2478_CR52","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1186\/s13046-023-02757-3","volume":"42","author":"Y Li","year":"2023","unstructured":"Li Y, Kong Y, An M, Luo Y, Zheng H, Lin Y, et al. ZEB1-mediated biogenesis of circnipbl sustains the metastasis of bladder cancer via Wnt\/beta-catenin pathway. J Exp Clin Cancer Res. 2023;42(1):191.","journal-title":"J Exp Clin Cancer Res"},{"issue":"1","key":"2478_CR53","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01390-y","volume":"20","author":"Y Zhang","year":"2021","unstructured":"Zhang Y, Jiang J, Zhang J, Shen H, Wang M, Guo Z, et al. Circdido1 inhibits gastric cancer progression by encoding a novel DIDO1-529aa protein and regulating PRDX2 protein stability. Mol Cancer. 2021;20(1):101.","journal-title":"Mol Cancer"},{"issue":"1","key":"2478_CR54","doi-asserted-by":"publisher","DOI":"10.1186\/s12943-021-01358-y","volume":"20","author":"T Jiang","year":"2021","unstructured":"Jiang T, Xia Y, Lv J, Li B, Li Y, Wang S, et al. A novel protein encoded by circMAPK1 inhibits progression of gastric cancer by suppressing activation of MAPK signaling. Mol Cancer. 2021;20(1):66.","journal-title":"Mol Cancer"},{"issue":"5","key":"2478_CR55","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1093\/neuonc\/noaa279","volume":"23","author":"Y Liu","year":"2021","unstructured":"Liu Y, Li Z, Zhang M, Zhou H, Wu X, Zhong J, et al. Rolling-translated EGFR variants sustain EGFR signaling and promote glioblastoma tumorigenicity. Neuro Oncol. 2021;23(5):743\u201356.","journal-title":"Neuro Oncol"},{"key":"2478_CR56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1476-4598-13-105","volume":"13","author":"J Ma","year":"2014","unstructured":"Ma J, Lyu H, Huang J, Liu B. Targeting of erbB3 receptor to overcome resistance in cancer treatment. Mol Cancer. 2014;13:105.","journal-title":"Mol Cancer"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12943-025-02478-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-025-02478-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T07:02:36Z","timestamp":1765436556000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12943-025-02478-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,11]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2478"],"URL":"https:\/\/doi.org\/10.1186\/s12943-025-02478-5","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,11]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was reviewed and approved by the Ethics Committee of the Sixth Affiliated Hospital of Sun Yat-sen University and the Sun Yat-Sen University Sixth Affiliated Hospital Institutional Animal Care and Use Committee.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"305"}}